481 related articles for article (PubMed ID: 26895832)
1. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
[TBL] [Abstract][Full Text] [Related]
2. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.
Phuong MS; Hernandez RE; Wolter DJ; Hoffman LR; Sad S
Cell Death Dis; 2021 Mar; 12(3):241. PubMed ID: 33664232
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome-mediated IL-1β production in humans with cystic fibrosis.
Tang A; Sharma A; Jen R; Hirschfeld AF; Chilvers MA; Lavoie PM; Turvey SE
PLoS One; 2012; 7(5):e37689. PubMed ID: 22649552
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
[TBL] [Abstract][Full Text] [Related]
6. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
7. Membrane vesicles from Pseudomonas aeruginosa activate the noncanonical inflammasome through caspase-5 in human monocytes.
Bitto NJ; Baker PJ; Dowling JK; Wray-McCann G; De Paoli A; Tran LS; Leung PL; Stacey KJ; Mansell A; Masters SL; Ferrero RL
Immunol Cell Biol; 2018 Nov; 96(10):1120-1130. PubMed ID: 30003588
[TBL] [Abstract][Full Text] [Related]
8. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
9. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
[TBL] [Abstract][Full Text] [Related]
11. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
[TBL] [Abstract][Full Text] [Related]
12. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.
Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T
Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544
[TBL] [Abstract][Full Text] [Related]
13. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
15. AIM2 inflammasome is dispensable for the host defense against Pseudomonas aeruginosa infection.
Pang Z; Sun G; Junkins RD; Lin TJ
Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):63-70. PubMed ID: 26107502
[TBL] [Abstract][Full Text] [Related]
16. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
17. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.
Anantharajah A; Faure E; Buyck JM; Sundin C; Lindmark T; Mecsas J; Yahr TL; Tulkens PM; Mingeot-Leclercq MP; Guery B; Van Bambeke F
J Infect Dis; 2016 Oct; 214(7):1105-16. PubMed ID: 27412581
[TBL] [Abstract][Full Text] [Related]
20. Inflammasome activation by Pseudomonas aeruginosa's ExlA pore-forming toxin is detrimental for the host.
Bouillot S; Pont S; Gallet B; Moriscot C; Deruelle V; Attrée I; Huber P
Cell Microbiol; 2020 Nov; 22(11):e13251. PubMed ID: 32779854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]